Targeted drug delivery by thermally responsive polymers.

Area of Science:

• Biotechnology
• Materials Science
• Oncology

Background:

• Solid tumors present challenges for drug delivery due to their complex microenvironment.
• Macromolecular carriers offer potential for targeted therapeutic delivery.
• Thermal targeting strategies can enhance drug accumulation in tumors.

Purpose of the Study:

• To review recent advancements in macromolecular carriers for thermal targeting of therapeutics to solid tumors.
• To evaluate the efficacy of thermally responsive polymers for enhanced tumor localization.
• To assess the impact of hyperthermia on drug delivery and cellular uptake.

Main Methods:

• Development of thermally responsive polymers: poly(NIPAAm) and elastin-like polypeptide (ELP).
• In vivo studies using fluorescent videomicroscopy and radiolabel distribution in tumor-bearing mice.
• Cell culture experiments to assess endocytotic uptake and cytotoxicity of ELP-drug conjugates.

Main Results:

• Hyperthermic targeting of ELP increased tumor localization approximately two-fold compared to non-hyperthermic conditions.
• Poly(NIPAAm) also showed enhanced tumor accumulation with hyperthermia, though to a lesser extent than ELP.
• Thermally triggered phase transition of ELP significantly enhanced endocytotic uptake in tumor cell lines.
• ELP-doxorubicin conjugates exhibited comparable cytotoxicity to free doxorubicin in vitro.

Conclusions:

• Thermally responsive polymers, particularly ELPs, are promising carriers for thermal targeting of therapeutics to solid tumors.
• Hyperthermia significantly improves the tumor-specific accumulation and cellular uptake of these macromolecular carriers.
• ELP-drug conjugates demonstrate potential for effective and targeted cancer therapy.